Stocks that Could Benefit from a Study of THCV
THCV, or tetrahydrocannabivarin may have the potential to help with energy, focus/attention, and eve appetite, weight/BMI. In fact, in a study of 900 adults aged 21 and older in the U.S., InMed Pharmaceuticals Inc.’s (NASDAQ: INM) subsidiary, BayMedica, will be providing rare cannabinoids for use in Radicle Science, Inc.’s Radicle Energy rare cannabinoid program. Tetrahydrocannabivarin, … Continue reading Stocks that Could Benefit from a Study of THCV